Publications

Chevron Deference on the Brink: Small Fish May Mean Big Changes for FDA

Co-Author, FDLI's Update Magazine

Chad Landmon, Hatch-Waxman & Biologics Chair, discusses Chevron and the changes it may mean for the FDA.